fluazuron has been researched along with Urinary Bladder Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dong, C; Ke, K; Kung, HF; Leung, KS; Li, H; Li, L; Lin, MC; Liu, X; Liu, XD; Shi, XN; Wong, MH; Yao, H; Zhu, Y | 1 |
1 other study(ies) available for fluazuron and Urinary Bladder Neoplasms
Article | Year |
---|---|
In silico prediction and in vitro and in vivo validation of acaricide fluazuron as a potential inhibitor of FGFR3 and a candidate anticancer drug for bladder carcinoma.
Topics: Acaricides; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Crystallography, X-Ray; Humans; In Vitro Techniques; Molecular Docking Simulation; Phenylurea Compounds; Phosphorylation; Receptor, Fibroblast Growth Factor, Type 3; Signal Transduction; Urinary Bladder Neoplasms | 2017 |